These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 28502142

  • 1. APRIL Level as a Marker of Disease Activity in Treated Rheumatoid Arthritis Patients: Association with Disease Activity and Anti-CCP Antibody.
    Boghdadi G, El-Sokkary RH, Elewa EA, Abbas SF.
    Egypt J Immunol; 2015 Jun; 22(2):31-39. PubMed ID: 28502142
    [Abstract] [Full Text] [Related]

  • 2. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
    Sun X, Zhao J, Liu R, Jia R, Sun L, Li X, Li Z.
    Scand J Rheumatol; 2013 Jun; 42(2):97-101. PubMed ID: 23311967
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z, Palafox-Sánchez CA, Parra-Rojas I, Martínez-Bonilla GE, del Toro-Arreola S, Ramírez-Dueñas MG, Ocampo-Bermudes G, Muñoz-Valle JF.
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [Abstract] [Full Text] [Related]

  • 4. GITRL is associated with increased autoantibody production in patients with rheumatoid arthritis.
    Li L, Wen W, Jia R, Li Y, Liu X, Sun X, Li Z.
    Clin Rheumatol; 2016 Sep; 35(9):2195-202. PubMed ID: 27098050
    [Abstract] [Full Text] [Related]

  • 5. Plasma level of neopterin as a marker of disease activity in treated rheumatoid arthritis patients: association with gender, disease activity and anti-CCP antibody.
    Arshadi D, Nikbin B, Shakiba Y, Kiani A, Jamshidi AR, Boroushaki MT.
    Int Immunopharmacol; 2013 Nov; 17(3):763-7. PubMed ID: 24055018
    [Abstract] [Full Text] [Related]

  • 6. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
    Shakiba Y, Koopah S, Jamshidi AR, Amirzargar AA, Massoud A, Kiani A, Nicknam MH, Nazari B, Nikbin B.
    Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
    [Abstract] [Full Text] [Related]

  • 7. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
    Manivel VA, Mullazehi M, Padyukov L, Westerlind H, Klareskog L, Alfredsson L, Saevarsdottir S, Rönnelid J.
    Ann Rheum Dis; 2017 Sep; 76(9):1529-1536. PubMed ID: 28336519
    [Abstract] [Full Text] [Related]

  • 8. The association of anti-CCP antibodies with disease activity in rheumatoid arthritis.
    Serdaroğlu M, Cakirbay H, Değer O, Cengiz S, Kul S.
    Rheumatol Int; 2008 Aug; 28(10):965-70. PubMed ID: 18418600
    [Abstract] [Full Text] [Related]

  • 9. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A, Plischke H, Kellner H, Gruber R.
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [Abstract] [Full Text] [Related]

  • 10. Performance characteristic of anti-cyclic citrullinated peptide (CCP) assay on Korean rheumatoid arthritis (RA) patients and healthy controls.
    Pyun JC, Lee EH, Han H, Kim HY, Kim HO, Kang MJ.
    J Pharm Biomed Anal; 2014 Apr; 92():69-73. PubMed ID: 24503194
    [Abstract] [Full Text] [Related]

  • 11. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O.
    Arthritis Rheum; 2006 Feb 15; 55(1):53-6. PubMed ID: 16463412
    [Abstract] [Full Text] [Related]

  • 12. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
    Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S.
    Ann Rheum Dis; 2006 Apr 15; 65(4):453-8. PubMed ID: 16176994
    [Abstract] [Full Text] [Related]

  • 13. Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis.
    Lee DM, Phillips R, Hagan EM, Chibnik LB, Costenbader KH, Schur PH.
    Ann Rheum Dis; 2009 Feb 15; 68(2):201-8. PubMed ID: 18390910
    [Abstract] [Full Text] [Related]

  • 14. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
    Agrawal S, Misra R, Aggarwal A.
    Clin Rheumatol; 2007 Feb 15; 26(2):201-4. PubMed ID: 16572283
    [Abstract] [Full Text] [Related]

  • 15. Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis.
    Arvikar SL, Collier DS, Fisher MC, Unizony S, Cohen GL, McHugh G, Kawai T, Strle K, Steere AC.
    Arthritis Res Ther; 2013 Feb 15; 15(5):R109. PubMed ID: 24017968
    [Abstract] [Full Text] [Related]

  • 16. Elevated Serum Levels of Interleukin-29 Are Associated with Disease Activity in Rheumatoid Arthritis Patients with Anti-Cyclic Citrullinated Peptide Antibodies.
    Chang QJ, Lv C, Zhao F, Xu TS, Li P.
    Tohoku J Exp Med; 2017 Feb 15; 241(2):89-95. PubMed ID: 28154345
    [Abstract] [Full Text] [Related]

  • 17. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis.
    Inanc N, Dalkilic E, Kamali S, Kasapoglu-Günal E, Elbir Y, Direskeneli H, Inanc M.
    Clin Rheumatol; 2007 Jan 15; 26(1):17-23. PubMed ID: 16538391
    [Abstract] [Full Text] [Related]

  • 18. Positive association between serum thymic stromal lymphopoietin and anti-citrullinated peptide antibodies in patients with rheumatoid arthritis.
    Koyama K, Ohba T, Haro H, Nakao A.
    Clin Exp Immunol; 2015 Aug 15; 181(2):239-43. PubMed ID: 25817699
    [Abstract] [Full Text] [Related]

  • 19. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.
    del Val del Amo N, Ibanez Bosch R, Fito Manteca C, Gutierrez Polo R, Loza Cortina E.
    Clin Exp Rheumatol; 2006 Aug 15; 24(3):281-6. PubMed ID: 16870095
    [Abstract] [Full Text] [Related]

  • 20. Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis patients without cardiovascular risk factors.
    Vázquez-Del Mercado M, Nuñez-Atahualpa L, Figueroa-Sánchez M, Gómez-Bañuelos E, Rocha-Muñoz AD, Martín-Márquez BT, Corona-Sanchez EG, Martínez-García EA, Macias-Reyes H, Gonzalez-Lopez L, Gamez-Nava JI, Navarro-Hernandez RE, Nuñez-Atahualpa MA, Andrade-Garduño J.
    Biomed Res Int; 2015 Aug 15; 2015():342649. PubMed ID: 25821796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.